In these carriers, the presence of RAD52 S346X allele was significantly associated with reduced risk of breast cancer: 159 RAD52 S346X heterozygotes did not have breast cancer compared to 118 RAD52 S346X heterozygotes who had breast cancer. This evidence concerns the gene RAD52 and breast cancer.